Clinical trial
Velcade (Bortezomib for Injection) Observational Study
NCT01675245 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Velcade (Bortezomib for Injection) Observational Study
- Lead sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- May 31, 2010
- Enrollment
- 532 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.